TransCode Therapeutics In...

NASDAQ: RNAZ · Real-Time Price · USD
10.97
-0.08 (-0.72%)
At close: Aug 15, 2025, 3:59 PM
10.98
0.09%
After-hours: Aug 15, 2025, 03:59 PM EDT

TransCode Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
5.81M 2.77M 4.97M 20.83M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
111.86K 111.86K -0.00 -0.00
Receivables
n/a n/a 360.23K n/a
Inventory
n/a n/a 554.33K n/a
Other Current Assets
828.22K 1.14M 1.5M 1.84M
Total Current Assets
7.09M 4.46M 7.38M 22.73M
Property-Plant & Equipment
89.31K 602.4K 208.58K 206.27K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
201.16K 714.26K 208.58K 206.27K
Total Assets
7.29M 5.17M 7.59M 22.94M
Account Payables
n/a n/a 4.35M 2.02M
Deferred Revenue
25.41K 27.06K n/a 30.53K
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
n/a n/a -4.35M -2.02M
Total Current Liabilities
2.77M 3.49M 4.35M 2.53M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
6.54M n/a n/a n/a
Total Long-Term Liabilities
6.54M 38.29K 4.35M n/a
Total Liabilities
9.31M 3.53M 4.35M 2.53M
Total Debt
38.29K 450.57K n/a n/a
Common Stock
103.00 63.00 1.3K 1.29K
Retained Earnings
-63.2M -46.42M -27.87M -10.31M
Comprehensive Income
n/a 0.00 0.00 0.00
Shareholders Equity
-2.02M 1.64M 3.24M 20.4M
Total Investments
n/a n/a 9.41 9.41